The Power of Proteases and their Inhibitors, Bridging Mechanisms and Therapeutics

For 2026, the conference will place a special emphasis on the mechanisms, functions, and translational implications of proteases and their inhibitors, highlighting their roles in health, disease, and therapeutic innovation. Sessions will explore the latest advances in protease biology, the development of next-generation inhibitors, and the impact of these molecules on drug discovery and patient care. Emerging technologies for monitoring protease activity and novel strategies for targeting proteolysis will be featured, as those that have led to recent breakthroughs, in SARS-CoV-2 main protease inhibitors in infectious disease, cancer, and cardiovascular research. The program will showcase world-renowned experts in protease structure, function, and inhibition, whose work spans innovative analytical platforms, the dynamics of proteases in complex biological systems, and the translation of fundamental discoveries into impactful therapies. The conference continues its tradition of fostering interdisciplinary collaborations, welcoming new researchers, and supporting the growth of promising scientists. A dedicated seminar will accompany the 2026 meeting, focused on mentoring and attracting junior scientists, graduate students, and postdoctoral fellows to this vibrant field. Whether your interests are in basic enzyme biochemistry, structural and chemical biology, or translational drug discovery, this conference offers a unique environment to explore the exciting intersection of protease research and therapeutic innovation.